Trial intelligence / Profile preview

Lingze Tablets Combined With Tamsulosin for Postoperative Prostate Surgery Symptoms

NCT07357324Phase 4Recruiting

Sponsor
The Fourth Affiliated Hospital of Zhejiang University School of Medicine
Start
Dec 2024
Primary completion
Dec 2026
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of Lingze in benign prostatic hyperplasia (BPH), nocturia, sponsored by The Fourth Affiliated Hospital of Zhejiang University School of Medicine. Started Dec 2024; status: recruiting.

02

Drugs

Lingze
03

Conditions

benign prostatic hyperplasia (BPH)nocturia

Beyond the preview

Go deeper on NCT07357324.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07357324.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call